National Doping Control Centre, Mahidol University

Site

National Doping Control Centre, Mahidol University

Accreditation No.

14567

Site No.

14620

Date of Accreditation

08 Aug 2001

Address

2nd Floor, Stang Mongkolsuk Building, 272 Rama VI Road, Ratchathewi District, BANGKOK
0
Thailand

andi.mahidol.ac.th

Contact

Dr Nathinee Panvisavas P: 66 23547148

Availability

Services available to external clients

Scope of Accreditation

National Doping Control Centre, Mahidol University

ISO/IEC 17025 (2017)

Legal - Analysis for compliance with WADA and sporting federation requirements

  • This facility complies with the requirements of the World Anti-Doping Agency (WADA) International Standard for Laboratories (ISL) (January 2021)
Service Product Determinant Technique Procedure
Analysis for sports drugs and drug metabolites Human blood M1: Manipulation of blood and blood components (blood analysis for the haematological model for athlete biological passport) Flow cytometry

standard method SSSS90

Human plasma; Human serum; Human urine S2: Peptide hormones, growth factors, related substances, and mimetics (erythropoiesis stimulating agents - SAR-PAGE, IEF-PAGE) Gel electrophoresis; Immunoblot; Immunopurification; Ultrafiltration (UF)

laboratory developed method SSSSE0: ITP, Qualitative CP

Human serum S2: Peptide hormones, growth factors, related substances, and mimetics (human growth hormone - isoform) Affinity-binding assay

standard method SSSSG0:  ITP, Quantitative CP

Human urine S3: Beta-2 agonists Enzymatic hydrolysis; GC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE)

laboratory developed method SSSSQ10: Quantitative CP

S2: Peptide hormones, growth factors, related substances, and mimetics; S5: Diuretics and masking agents LC-MSn (n≥1); Solid phase extraction (SPE)

laboratory developed method SSSSB0: ITP, Qualitative CP

S6: Stimulants GC-MSn (n≥1); Liquid liquid extraction

laboratory developed method SSSS20: Qualitative CP

S1: Anabolic agents; S2: Peptide hormones, growth factors, related substances, and mimetics LC-MSn (n≥1); Solid phase extraction (SPE)

laboratory developed method SSSSN0: ITP, Qualitative CP

S2: Peptide hormones, growth factors, related substances, and mimetics (chorionic gonadotrophin and luteinizing hormone) Affinity-binding assay

laboratory developed method SSSSI0: ITP

M1: Manipulation of blood and blood components; P1: Beta-blockers; S1: Anabolic agents; S2: Peptide hormones, growth factors, related substances, and mimetics; S3: Beta-2 agonists; S4: Hormone and metabolic modulators; S5: Diuretics and masking agents; S6: Stimulants; S7: Narcotics; S8: Cannabinoids; S9: Glucocorticoids Dilute and shoot; Enzymatic hydrolysis; LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE)

laboratory developed method SSSSC0: ITP, Qualitative CP

S1: Anabolic agents (including steroid profiling) Enzymatic hydrolysis; GC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE)

laboratory developed method SSSS40: ITP, Qualitative CP

S7: Narcotics GC-MSn (n≥1); Liquid liquid extraction

laboratory developed method SSSSQ7: Quantitative CP

S6: Stimulants; S7: Narcotics GC-MSn (n≥1); Liquid liquid extraction

standard method SSSS10: Qualitative CP

S5: Diuretics and masking agents Chemical hydrolysis; GC-MSn (n≥1)

laboratory developed method SSSSH0: Qualitative CP

P1: Beta-blockers; S3: Beta-2 agonists; S4: Hormone and metabolic modulators; S5: Diuretics and masking agents; S6: Stimulants; S7: Narcotics Dilute and shoot; LC-MSn (n≥1)

laboratory developed method SSSSD0: ITP, Qualitative CP

S6: Stimulants GC-MSn (n≥1); GC-NPD; Liquid liquid extraction

laboratory developed method SSSSQ2: Qualitative CP, Quantitative CP

pH Potentiometric standard method SSSSP0
S1: Anabolic agents Enzymatic hydrolysis; GC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE)

laboratory developed method SSSSQ3:Quantitative CP

S3: Beta-2 agonists Enzymatic hydrolysis; LC-MSn (n≥1); Liquid liquid extraction

laboratory developed method SSSSQ9: Quantitative CP

S8: Cannabinoids GC-MSn (n≥1); Solid phase extraction (SPE)

laboratory developed method SSSSQ5: Quantitative CP

S1: Anabolic agents Enzymatic hydrolysis; GC-MSn (n≥1); Gas chromatography - Combustion - Isotope ratio mass spectrometry (GC-C-IRMS); Liquid liquid extraction; Solid phase extraction (SPE)

laboratory developed method SSSSR0: Quantitative CP

Specific gravity Refractometry standard method SSSSS0

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.